Mild Cognitive Impairment - it's not dementia, but it is just as important for pharmacists to know what it is and how to manage it.
August 2022 ･ 30 min watch
- Mild Cognitive Impairment (MCI) and the changes that occur in individuals with MCI
- The importance of early detection and process of diagnosis of MCI
- The underlying causes of MCI, risk factors for progression and prevention strategies
- Areas where pharmacists can make a real difference for patients and their families.
Mild Cognitive Impairment (MCI) currently affects around 1 million people in Australia. Having MCI doesn’t mean a person has dementia or even that they will go on to develop dementia, however early identification and management is critical to influence the trajectory for these patients. Pharmacists are ideally placed to identify patients with symptoms of mild cognitive impairment and to help implement healthcare strategies that can reverse, stabilise or slow the progression of this condition.
Speaker: Associate Professor Michael Woodward, Geriatrician & Director at Aged Care Research, Austin Health
Pharmacists can self-record Group 1 CPD credit for this webinar recording.
Nutricia products are intended for the nutritional management of diseases and related medical conditions and therefore should be used under medical supervision.
Please tell us who you are
?ts=1770366114577&fmt=webp-alpha&dpr=off){kind=small}
Important notice and declaration
Breast milk is best for babies. Professional advice should be followed before using an infant formula. Introducing partial bottle feeding could negatively affect breast feeding. Good maternal nutrition is important for breast feeding and reversing a decision not to breast feed may be difficult. Infant formula should always be used as directed. Proper use of an infant formula is important to the health of the infant. Social and financial implications should be considered when selecting a method of feeding.
The information provided on this website is intended for use by healthcare professionals only. It is a condition of use of this site that you are a healthcare professional within the meaning of the Marketing in Australia of Infant Formulas (MAIF) Agreement or health practitioner within the meaning of the Therapeutic Goods Act 1989 (Cth). By accessing and using this website you acknowledge and declare that you are a registered healthcare professional. The content on this site is intended for general information and educational purposes only.